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ABSTRACT
Dermatofibrosarcoma protuberans (DFSP) is an indolent sarcoma known for its propen-
sity for local invasive growth and recurrence. It typically presents as a protuberant 
tumor mass. Rare nonprotuberant presentations have recently been described; these 
invariably present as pigmented or depressed plaques. Lesions arising in the subcutane-
ous compartment and without cutaneous manifestations have rarely been reported or 
emphasized in the literature. Here we report a case of deep DFSP that lacked discern-
ible epidermal or dermal changes, was mistaken for a lipoma, and localized entirely 
within the subcutaneous compartment. Ultrasonography may not be useful in differen-
tiating DFSP from benign tumors. In addition, a review of the English language litera-
ture revealed that these deep-seated tumors might be more common than originally 
believed. For this purpose, the current case is presented to raise awareness for DFSP, 
which can be present entirely in the subcutis without cutaneous manifestations and 
thus easily overlooked.
Copyright © 2010, Taiwanese Dermatological Association. 
Published by Elsevier Taiwan LLC. All rights reserved.
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Introduction
Dermatofibrosarcoma protuberans (DFSP) is a common cu-
taneous sarcoma representing approximately 6% of all ma-
lignant tumors with soft tissue involvement.1 Clinically, it is 
associated with unique cutaneous findings compatible with 
a tumor of dermal origin, typically presenting as a protrud-
ing “protuberant” mass or less commonly as a depressed 
and/or pigmented plaque.2 While it rarely metastasizes, this 
indolent tumor has great propensity for deep local inva-
sion. Thus, wide surgical excision or Mohs micrographic 
surgery with or without radiotherapy are generally consid-
ered to be the best treatments. Here we describe a case of 
DFSP lacking the cutaneous findings it typically associates 
with, and is located entirely in the subcutaneous compart-
ment. A review of the literature reveals few cases of deep 
DFSP presenting without cutaneous features.3–5 
Case report 
A 34-year-old man with a history of a left upper chest wall 
tumor excised two years ago presented at our clinic with a 
right upper back mass of two years’ duration. Compression 
symptoms during sleep were noted in the previous few weeks. 
No pain, localized heat or redness was otherwise reported. 
There was neither personal nor familial history of cancer.
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revealed a large subcutaneous tumor (Figure 2A) composed 
of spindle cells forming storiform growth patterns with scat-
tered mitotic figures and entrapped fat cells forming a hon-
eycomb (Figure 2B).
Immunohistochemical study of the sample showed 
the tumor cells were positive for CD34, and negative for 
factor XIIIa (Figures 3A and 3B, respectively); a diagnosis of 
deep DFSP was made. Magnetic resonance imaging (MRI) 
Physical examination revealed a movable, slightly indu-
rated mass without any epidermal change (Figure 1A). Soft 
tissue ultrasonography revealed a poorly defined, heteroge-
neous subcutaneous tumor, measuring 2.17 x 0.74 cm 
(Figure 1B). Excisional biopsy was arranged under the im-
pression of a lipoma. A multilobulated and indurated tumor 
in the subcutaneous tissue was noted intraoperatively, fa-
voring nodular fascitis. Serial histopathologic examinations 
A B
Figure 1 (A) A movable (non-fixated) and slightly indurated mass without any epidermal change on the posterior aspect of the right shoulder. (B) Soft 
tissue ultrasonography revealed a poorly defined heterogeneous subcutaneous tumor measuring 2.17 × 0.74 cm, without posterior enhancement.
A B
Figure 2 (A) The tumor is grossly located in the subcutaneous compartment. (B) Histopathological examination revealed a large subcutaneous tumor 
composed of spindle cells forming storiform growth patterns with scattered mitotic figures and entrapped fat cells forming a honeycomb (H&E, 200×).
A B
Figure 3 (A) The tumor cells were positive for CD34 (H&E, 400×). (B) The tumor cells were negative for factor XIIIa (H&E, 400×).
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noted to be inversely proportionate to the tumor depth in 
dermatofibromas and DFSP. Specifically, the critical dis-
tance necessary for DFSP-induced epidermal hyperplasia 
was 0.19 ± 0.16 mm as measured from stromal proliferation 
to the tip of the dermal papilla. Observation of epidermal 
hyperplasia was thus proposed to be attributable to cy-
tokine diffusion to the epidermis.18 Therefore, purely sub-
cutaneously located DFSP presenting without any skin 
surface changes should not be regarded as coincidental, 
but should instead be expected to have little cutaneous ef-
fect. This lack of epidermal or even dermal changes is par-
ticularly alarming, since DFSP are typically diagnosed after 
biopsy of a clinically suspect lesion.
The true epidemiology of these deep-seated lesions is 
not known, since they may be present, as in our case, en-
tirely devoid of skin surface changes for many years. This is 
clinically alarming, since deep lesions would lack the typi-
cal clinical presentations of DFSP or other malignant tu-
mors that would otherwise warrant further biopsy. In those 
unable or not compliant to biopsy, MRI may be an early 
viable alternative. In a series of 10 DFSP patients who un-
derwent MRI, the results were found to be consistent with 
other soft tissue sarcomas. Notably, 3 of these 10 cases had 
tumors primarily located in the subcutis; one of these three 
was purely subcutaneous after a histopathologic review. 
Unfortunately, clinical presentation was lacking due to the 
retrospective nature of the study. Although limited in case 
number, this study nevertheless raises the possibility that 
DFSP has high propensity (30%) to be located deep in the 
dermis.19,20
In 2005, Martin et al16 reviewed questionnaires from 143 
cases of DFSP. Sixty-two were initially nonprotuberant (43%). 
Of these, 18 (29%) were “morphea-like”, 12 (19%) were “at-
rophoderma-like” and 26 (42%) were “angioma-like”. The 
pathological, immunohistochemical and cytogenetic findings 
of “non-protuberans” DFSP and “classical” protuberant DFSP 
are otherwise identical and believed to be at different stages of 
the same disease spectrum. Progression from nonprotuberant 
to protuberant DFSP took an average of 7.6 ± 9.3 years 
(mean ± SD).16 With its proclivity for deep invasion, subse-
quent upward growth of subcutaneous DFSP toward the der-
mis is unlikely to occur to any great extent. The true prevalence 
of DFSP may therefore be underestimated and lacking a “pro-
tuberans” morphology. Thus, the current methodology of clas-
sification via clinical presentations should be reconsidered.
In clinical settings, ultrasonography is frequently used in 
early assessment of tumor characteristics. Sonography is an 
excellent imaging modality to determine the cystic or solid 
nature of a mass and its anatomic relation to adjoining 
structures. Masses can be characterized in terms of size, 
number and vascularity in addition to the presence of cal-
cification or ossification.21 Because of their heterogeneous 
but mostly reproducible echogenicity and relatively typical 
sonographic appearance, subcutaneous lesions of various 
revealed post-operatively-enhanced tissue abutting the su-
perficial fascia of supraspinatus tendon but without deep in-
vasion. Chest film, abdominal ultrasonography, computed 
tomography scan and bone scan failed to reveal distant me-
tastasis. Definitive treatment via wide excision with 2.5 cm 
lateral margins and a 4.5 cm deep margin combined with 
subsequent rotational fasciocutaneous flap reconstruction 
was performed. Subsequent adjuvant radiotherapy was also 
ongoing.
Discussion
DFSP is believed to be a cutaneous sarcoma of the dermis 
with potential for deep invasion of subcutaneous structures 
but rarely metastasizing.6 It is typically located over the 
trunk and proximal extremities5 but may occur on any part 
of the body.7 Incidence rate has been estimated to be between 
0.8 to 5 cases per million persons per year.7,8 This represented 
approximately 6.2% of the 39,179 malignant soft tissue tu-
mors diagnosed during a 10-year retrospective analysis.1
Traditionally, DFSP is considered a cutaneous tumor fixed 
to the dermis and thus able to move freely over deeper-lying 
tissue.9 However, recent reports10–13 have shown primary 
DFSP presenting in sites without dermal involvement. DFSP 
confined to the subcutaneous layer have also been recognized 
as “deep DFSP”2,4 or “subcutaneous DFSP”.5 These cases 
challenges the conventional belief of DFSP as a cutaneous 
tumor with primary growth in dermis. Further research into 
the true histogenetic etiology of DFSP is needed to include 
cell types of the hypodermis and vascular compartments, 
instead of or in addition to those lineages typically seen in 
the dermal compartment.
Regardless of tumor location, previous reports of DFSP 
almost invariably presented with skin surface findings, ei-
ther due to dermal involvement or secondary epidermal 
changes. Two primary groups have been elucidated, including 
“classical” protruding DFSP with elevation or protrusion, and 
“non-protuberans” DFSP with atrophy or depression.14–16 A 
case of pedunculated DFSP clinically believed to be neu-
rofibroma or fibroepithelioma has also been reported.17 
Previously, Ramakrishnan et al3 reported a lesion without 
any evidence of skin involvement; they noted a DFSP en-
veloped in adipose tissue without any dermal infiltration in 
histopathological analyses of both the core biopsy sample 
and the excised tumor. This presentation was similar to 
our case: both DFSP presented entirely without epidermal 
changes, elevation-depression, erythema, or pigmentary al-
terations on the skin surface and both were confined within 
the subcutaneous compartment.
Epidermal involvement may be deficient due to the deep 
location of the tumors, which were 0.4 cm and 1 cm in case 
of the current and the Ramakrishnan et al study,3 respec-
tively, since the level of epidermal hyperplasia has been 
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origins, especially fluid cysts, can be easily distinguished 
from each other.22 Although lipomas have been classically 
described as homogeneous and hyperechoic, there are fre-
quent exceptions.23 As a consequence, the diagnosis of benign 
lipomatous tumors can often be problematic, since echo-
genecity corresponds to that of the surrounding fatty tissue 
and is in case of fibrolipoma, hyperechoic compared to the 
adjacent tissue or in case of an angiolipoma, hypoechoic.22
Diagnosis of a lipoma on sonography should be made 
with caution, because there can be a myriad of malignant 
or benign fat-containing lesions, including low-grade li-
posarcoma and angiolipoma which can mimic lipomas.21 
Similarly, ultrasonographic features of DFSP have varied as 
well. Studies have shown echogenicity to be primarily hypo-
echoic or mixed hyperechoic, while margins are typically 
well-defined or irregular with pseudopodia-like protusions; 
vascularity, a feature favoring malignancy, has also been 
varied.24,25 Similar to DFSP, lipoma has been shown to vary 
in echogenicity, margin delineation and tumor location in 
several publications.23,26
DFSP can be mainly or completely located in the subcuta-
neous compartment, and thus may be clinically indistinguish-
able from lipomas or other subcutaneous tumors. Without 
clinical indicators as to the aggressive nature of these non-
cutaneous, asymptomatic, slow-growing and deep-seated 
DFSP, a dichotomous distinction between these and other 
more benign lesions may not be readily evident. It is possible 
that these clinically unidentifiable DFSP are underdiagnosed. 
Enlargement of any mass regardless of lesion duration should 
prompt immediate suspicion of malignancy; therefore, ag-
gressive cutaneous biopsy of all progressive lesions is rec-
ommended for early diagnosis. Of the available imaging 
modalities, MRI may aid the diagnostic process, since fea-
tures of DFSP consistent with soft tissue sarcoma are often 
seen.19 Ultrasonography may be insufficient for differentiating 
between deep DFSP and otherwise benign tumors such as 
lipoma, but more cases are needed to clarify its role.
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